Mediwound Cash Conversion Cycle from 2010 to 2026
| MDWD Stock | USD 17.27 0.14 0.82% |
Cash Conversion Cycle | First Reported 2010-12-31 | Previous Quarter 89.51 | Current Value 85.04 | Quarterly Volatility 878.21519262 |
Check Mediwound financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mediwound's main balance sheet or income statement drivers, such as Depreciation And Amortization of 869.2 K, Interest Expense of 436.1 K or Selling General Administrative of 11.7 M, as well as many indicators such as Price To Sales Ratio of 9.58, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mediwound financial statements analysis is a perfect complement when working with Mediwound Valuation or Volatility modules.
Mediwound | Cash Conversion Cycle | Build AI portfolio with Mediwound Stock |
Analyzing Mediwound's Cash Conversion Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Cash Conversion Cycle has evolved provides context for assessing Mediwound's current valuation and future prospects.
Latest Mediwound's Cash Conversion Cycle Growth Pattern
Below is the plot of the Cash Conversion Cycle of Mediwound over the last few years. It is Mediwound's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mediwound's overall financial position and show how it may be relating to other accounts over time.
| Cash Conversion Cycle | 10 Years Trend |
|
Cash Conversion Cycle |
| Timeline |
Mediwound Cash Conversion Cycle Regression Statistics
| Arithmetic Mean | 319.41 | |
| Coefficient Of Variation | 274.95 | |
| Mean Deviation | 540.12 | |
| Median | 89.51 | |
| Standard Deviation | 878.22 | |
| Sample Variance | 771,262 | |
| Range | 4.2K | |
| R-Value | (0.17) | |
| Mean Square Error | 797,876 | |
| R-Squared | 0.03 | |
| Significance | 0.51 | |
| Slope | (30.20) | |
| Total Sum of Squares | 12.3M |
Mediwound Cash Conversion Cycle History
About Mediwound Financial Statements
Mediwound stakeholders use historical fundamental indicators, such as Mediwound's Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Mediwound investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mediwound's assets and liabilities are reflected in the revenues and expenses on Mediwound's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mediwound. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Conversion Cycle | 89.51 | 85.04 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:Check out the analysis of Mediwound Correlation against competitors. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Will Pharmaceuticals sector continue expanding? Could Mediwound diversify its offerings? Factors like these will boost the valuation of Mediwound. Expected growth trajectory for Mediwound significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mediwound data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.84) | Revenue Per Share | Quarterly Revenue Growth 0.247 | Return On Assets | Return On Equity |
Investors evaluate Mediwound using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mediwound's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mediwound's market price to deviate significantly from intrinsic value.
Understanding that Mediwound's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mediwound represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mediwound's market price signifies the transaction level at which participants voluntarily complete trades.